Allarity Therapeutics, Inc. (ALLR)

Allarity Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	25.2	19.53	0.17	2.03	19.56	0.3
Short-Term Investments	-	0.07	0.06	0.05	0.4	0.07
Cash & Short-Term Investments	25.2	19.61	0.22	2.08	19.96	0.37
Cash Growth	7977.24%	8731.08%	-89.33%	-89.58%	5353.01%	-76.05%
Other Receivables	1.12	2.23	0.95	0.87	1.35	1.12
Receivables	1.12	2.23	0.95	0.87	1.35	1.12
Prepaid Expenses	0.49	0.51	0.78	0.59	0.04	0.17
Other Current Assets	0.11	-	0.02	1.43	0.07	0.05
Total Current Assets	29.42	22.34	1.97	4.97	21.4	1.72
Property, Plant & Equipment	0.31	0.31	0.02	0.03	0.09	0.35
Long-Term Investments	-	-	-	-	-	0.85
Other Intangible Assets	-	-	9.87	9.55	28.14	30.49
Total Assets	29.73	22.65	11.86	14.54	49.63	33.4
Accounts Payable	4.35	4.18	8.42	6.25	0.7	2.12
Accrued Expenses	2.78	2.73	1.31	1.9	8.59	1.84
Short-Term Debt	-	-	-	2.64	-	1.41
Current Portion of Long-Term Debt	1.36	1.35	1.3	-	-	-
Current Portion of Leases	-	-	-	0.01	0.1	0.11
Current Income Taxes Payable	0.08	0.07	0.06	0.04	0.06	0.06
Other Current Liabilities	2.5	2.5	3.08	0.37	11.27	-
Total Current Liabilities	11.06	10.84	14.17	11.22	20.72	5.53
Long-Term Debt	-	-	-	1.08	0.98	0.88
Long-Term Leases	-	-	-	-	0.01	0.27
Long-Term Deferred Tax Liabilities	-	-	0.45	0.35	1.96	2.14
Other Long-Term Liabilities	-	-	-	-	7.18	0.15
Total Liabilities	11.06	10.84	14.61	12.65	30.85	8.96
Common Stock	0	0	-	-	0	0.43
Additional Paid-In Capital	141	131.13	90.37	83.16	85.24	62.48
Retained Earnings	-121.7	-118.97	-94.45	-82.55	-66.49	-39.84
Comprehensive Income & Other	-0.63	-0.35	-0.41	-0.72	-0.6	1.38
Total Common Equity	18.67	11.81	-4.49	-0.11	18.15	24.44
Shareholders' Equity	18.67	11.81	-2.75	1.89	18.78	24.44
Total Liabilities & Equity	29.73	22.65	11.86	14.54	49.63	33.4
Total Debt	1.36	1.35	1.3	3.74	1.09	2.67
Net Cash (Debt)	23.84	18.26	-1.08	-1.66	18.87	-2.3
Net Cash Per Share	5.43	11.36	-	-	-	-
Filing Date Shares Outstanding	15.08	17.01	0.01	0	0	-
Total Common Shares Outstanding	17.02	7.3	-	0	0	-
Working Capital	18.36	11.5	-12.2	-6.25	0.69	-3.82
Book Value Per Share	1.10	1.62	-	-5947.37	1815200.00	-
Tangible Book Value	18.67	11.81	-14.36	-9.66	-9.98	-6.05
Tangible Book Value Per Share	1.10	1.62	-	-508526.32	-998300.00	-
Machinery	-	-	-	-	-	0.36

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q